Tech Company Financing Transactions
Mersana Therapeutics Funding Round
Mersana Therapeutics secured a $27 million Series A investment round on 7/31/2012. Investors included New Enterprise Associates, F-Prime Capital and Harris & Harris Group.
Transaction Overview
New Enterprise Associates (Lead Investor) (David Mott)
F-Prime Capital (Thomas Beck)
ProQuest Investments (Joyce Tsang)
Rho Ventures (Martin Vogelbaum)
Company Information
Cambridge, MA 02139
USA
Management Team
Browse more venture capital transactions:
Prev: 7/31/2012: BringMeTheNews venture capital transaction
Next: 7/31/2012: Videolicious venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs